Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Digestive Neuroendocrine Tumors × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 532 Multiple Endocrine Neoplasia Type 1 187 Pituitary Neoplasms 183 Thyroid Cancer, Papillary 176 Pheochromocytoma 151 Carcinoma, Neuroendocrine 138 Thyroid Neoplasms 130 Neoplasms 107 Carcinoid Tumor 99 Paraganglioma 97 Adrenocortical Carcinoma 92 Thyroid Carcinoma, Anaplastic 82 Pancreatic Neoplasms 69 Neoplasm Metastasis 68 Adrenal Gland Neoplasms 61 Insulinoma 60 Gastro-enteropancreatic neuroendocrine tumor 58 Carcinoma, Medullary 58 Carcinoma, Non-Small-Cell Lung 57 Adenocarcinoma, Follicular 57 Breast Neoplasms 56 Adenoma, Islet Cell 56 Sarcoma 49 Lung Neoplasms 49 Colorectal Neoplasms 49 Carcinoma, Renal Cell 49 Melanoma 47 Small Cell Lung Carcinoma 45 Prostatic Neoplasms 44 Carcinoma, Hepatocellular 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated

Digestive Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡